ZVSAZyVersa Therapeutics, Inc.

ZVSA Stock Price, Valuation & Chart | ZyVersa Therapeutics, Inc.

Compare

$0.100+0.00 (+4.94%)

At close · 02 Sept 2026, 03:52 pm

Sector: Healthcare Industry: Biotechnology ZVSA intrinsic value ZVSA calculated fair value vs price

Overview Financials Dividends Ratios

ZVSA Historical price chart

ZVSA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization841.09K

PE Ratio-0.03

EPS-3.67

Trading Volume1.10K

Today's High/Low0.1/0.1

Dividend Yield0.00

52 Week High/Low0.3/0.08

Shares Outstanding8.10M

ZVSA Financial Statement

ZVSA Analyst ratings

ZVSA Analysis & performance metrics

ZVSA Company profile

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages…

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of…

ZVSA Management team

Name

Position

Pablo A. Guzman FACC, M.D.

Chief Medical Officer, Senior Vice President of Medical Affairs & Chairman of Renal Scientific Advisory Board

Karen A. Cashmere

Chief Commercial Officer

Stephen C. GloverCEO

Co-Founder, Chairman, Chief Executive Officer & President

Peter WolfeCFO

Chief Financial Officer & Secretary

Name

Position

Pablo A. Guzman FACC, M.D.

Chief Medical Officer, Senior Vice President of Medical Affairs & Chairman of Renal Scientific Advisory Board

Karen A. Cashmere

Chief Commercial Officer

Stephen C. GloverCEO

Co-Founder, Chairman, Chief Executive Officer & President

Peter WolfeCFO

Chief Financial Officer & Secretary

Management Team

Pablo A. Guzman FACC, M.D.

Chief Medical Officer, Senior Vice President of Medical Affairs & Chairman of Renal Scientific Advisory Board

Karen A. Cashmere

Chief Commercial Officer

Stephen C. GloverCEO

Co-Founder, Chairman, Chief Executive Officer & President

Peter WolfeCFO

Chief Financial Officer & Secretary

Management

Pablo A. Guzman FACC, M.D.

Chief Medical Officer, Senior Vice President of Medical Affairs & Chairman of Renal Scientific Advisory Board

Karen A. Cashmere

Chief Commercial Officer

Stephen C. GloverCEO

Co-Founder, Chairman, Chief Executive Officer & President

Peter WolfeCFO

Chief Financial Officer & Secretary

Total 4 executives

ZVSA Frequently asked questions

What is ZyVersa Therapeutics, Inc. (ZVSA) Stock Price?

Current stock price of ZyVersa Therapeutics, Inc. (ZVSA) stock is $0.100. The stock price is +4.94% higher in the session. The intraday range can be seen from this page. Volume of ZyVersa Therapeutics, Inc. (ZVSA) stock is 1.10K.

Last updated at 02 Sept 2026, 03:52 pm.

Why is the ZyVersa Therapeutics, Inc. (ZVSA) stock price going up or down today?

The stock price of ZyVersa Therapeutics, Inc. (ZVSA) can change with earnings, company news, and overall market sentiment. ZyVersa Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the ZyVersa Therapeutics, Inc. stock expensive at its current price?

Whether ZyVersa Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ZVSA on this page is -0.03. EPS on this page is -3.67. Compare those figures with peers and growth expectations before deciding if the current ZyVersa Therapeutics, Inc. price is justified.

How has the stock price of ZyVersa Therapeutics, Inc. (ZVSA) performed historically?

Historical performance for ZyVersa Therapeutics, Inc. (ZVSA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ZVSA reacted to past earnings and market events.

Should I buy ZyVersa Therapeutics, Inc. (ZVSA) stock, at this price?

Buying ZyVersa Therapeutics, Inc. (ZVSA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.